Prior to becoming Director of the Canadian Cancer Trials Group (CCTG) in 2014, Dr. Janet Dancey was Director, Translational Research – Clinical at CCTG. She is also Scientific Director of the CCTG Network and Director of the High Impact Clinical Trials Program at the Ontario Institute for Cancer Research. She is also a Professor in the Department of Oncology at Queen’s University. Dr. Dancey has special expertise in drug development, linking drug and biomarker development, and associated clinical trials methodology.
Director of the Canadian Cancer Trials Group